Table 4. Generated population specific seated/supine AC and WC cutoff points with averaged and standard deviation for the cardiometabolic risk factors chosen in the current study.
| Seated | Supine | |||||||
|---|---|---|---|---|---|---|---|---|
| Anthropometric Measurements | AC < 101 (cm) | AC ≥ 101 (cm) | WC < 89.1 (cm) | WC ≥ 89.1 (cm) | AC < 88.3 (cm) | AC ≥ 88.3 (cm) | WC < 86.5 (cm) | WC ≥ 86.5 (cm) |
| Body Mass (kg) | 72.3 ± 11.7 | 84.6 ± 12.6† | 72.3 ± 11.2 | 85.9 ± 12.5† | 72.3 ± 11.7 | 84.6 ± 12.6† | 72.6 ± 11.2 | 85.4 ± 13† |
| BMI (cm) | 22.2 ± 3.6 | 27.5 ± 2.4* | 22.6 ± 3.6 | 27.6 ± 2.7* | 22.2 ± 3.6 | 27.5 ± 2.4* | 22.43± 3.5 | 27.8 ± 2.3* |
| Seated AC (cm) | 89.7 ± 9.2 | 111.0 ± 6.9* | 91.3 ± 10.1 | 111.1 ± 7.9* | 89.7 ± 9.2 | 111.0 ± 6.9* | 90.7 ± 9.5 | 118.8 ± 6.6* |
| Seated WC (cm) | 81.6 ± 5.8 | 96.0 ± 5.9* | 81.8 ± 5.4 | 97.2 ± 4.8* | 81.6 ± 5.8 | 96.0 ± 5.9* | 82.0 ± 5.7 | 97.0 ± 5.2* |
| Supine AC (cm) | 77.3 ± 7.8 | 97.9 ± 6.1* | 79.3 ± 9.5 | 97.6 ± 7.4* | 77.3 ± 7.8 | 97.9 ± 6.1* | 78.7 ± 8.9 | 98.3 ± 6.3* |
| Supine WC (cm) | 76.0 ± 6.6 | 95.8 ± 5.8* | 77.4 ± 7.8 | 96.1 ± 6.3* | 76.0 ± 6.6 | 95.8 ± 5.8* | 76.8 ± 6.9 | 96.8 ± 5.0* |
| Supine HC (cm) | 92.3 ± 6.7 | 102.7 ± 10.1† | 92.7 ± 6.7 | 103.2 ± 10.5† | 92.3 ± 6.7 | 102.7 ± 10.1† | 92.8 ± 6.7 | 103.2 ± 10.6† |
| Waist:Hip ratio | 0.8 ± 0.1 | 0.9 ± 0.1* | 0.8 ± 0.1 | 0.9 ± 0.1* | 0.8 ± 0.1 | 0.9 ± 0.1* | 0.8 ± 0.1 | 0.9 ± 0.1* |
| MRI Outcomes | ||||||||
| MRI VATcsa (cm2) a | 53.3 ± 35.2 | 143.2 ± 45.6* | 64.4 ± 55.4 | 139.9 ± 39.0* | 53.3 ± 35.2 | 143.2 ± 45.6* | 52.6 ± 33.4 | 152.9 ± 33.9* |
| MRI VAT Volume (cm3) a | 3154 ± 2252 | 7578 ± 2665* | 3413 ± 3051 | 7932 ± 1966* | 2767 ± 2111 | 7873 ± 2604* | 2690 ± 2018 | 8143 ± 1997* |
| MRI VATcsa/Total a | 0.09 ± 0.06 | 0.19 ± 0.07* | 0.11 ± 0.08 | 0.19 ± 0.05† | 0.09 ± 0.06 | 0.19 ± 0.07* | 0.09 ± 0.05 | 0.20 ± 0.06* |
| MRI VAT:SAT ratio a | 0.52 ± 0.27 | 0.86 ± 0.44† | 0.58 ± 0.38 | 0.83 ± 0.40 | 0.52 ± 0.27 | 0.86 ± 0.44† | 0.50 ± 0.26 | 0.92 ± 0.42† |
| Blood Pressure | ||||||||
| SYS (mm/Hg) | 116 ± 21 | 119 ± 19 | 117 ± 19 | 117 ± 21 | 116 ± 21 | 119 ± 19 | 116 ± 20 | 119 ± 20 |
| DIA (mm/Hg) | 71 ± 10 | 74 ± 11 | 72 ± 10 | 74 ± 10 | 81 ± 14 | 74 ± 11 | 71 ± 9 | 76 ± 10 |
| Whole-body Outcomes | ||||||||
| VO2 peak (L/min) c | 0.65 ± 0.23 | 0.48 ± 0.17 | 0.59 ± 0.23 | 0.51 ± 0.19 | 0.65 ± 0.23 | 0.48 ± 0.17 | 0.65 ± 0.20 | 0.46 ± 0.17 |
| BMR (Kcal/day) | 1058 ± 227 | 1215 ± 316 | 1051 ± 218 | 1240 ± 321 | 1058 ± 227 | 1215 ± 316 | 1053 ± 217 | 1238 ± 324 |
| Lipid Profile | ||||||||
| LDL-C (mg/dL) | 85.1 ± 19.3 | 100.1 ± 32.0 | 86.6 ± 22.3 | 99.8 ± 31.2 | 85.1 ± 19.3 | 100.1 ± 32.0 | 88.08 ± 21.1 | 98 ± 32.9 |
| HDL-C (mg/dL) | 35.8 ± 9.2 | 34.2 ± 7.2 | 35.3 ± 9.2 | 34.7 ± 7.0 | 35.8 ± 9.2 | 34.2 ± 7.2 | 35.9 ± 8.8 | 33.9 ± 7.5 |
| Non-HDL (mg/dL) | 102.1 ± 23.0 | 128.2 ± 26.7† | 105.7 ± 25.5 | 126.5 ± 27.1 | 102.1 ± 23.0 | 128.2 ± 26.7† | 105.8 ± 25.5 | 126.3 ± 27.3 |
| Total Cholesterol (mg/dL) | 137.9 ± 20.6 | 162.4 ± 31.9† | 140.9 ± 24.1 | 161.2 ± 31.7 | 137.9 ± 20.6 | 162.4 ± 31.9† | 141.8 ± 23.7 | 160.2 ± 32.8 |
| TG (mg/dL) | 85.1 ± 25.0 | 137.0 ± 64.2† | 95.3 ± 38.6 | 129.9 ± 66.2 | 85.1 ± 25.0 | 137.0 ± 64.2† | 88.8 ± 26.9 | 137.9 ± 67.6 |
| FFA (pg/mL) | 354.2 ± 193.5 | 373.2 ± 192.8 | 353.8 ± 201.3 | 375.6 ± 182.5 | 354.2 ± 193.5 | 373.2 ± 192.8 | 335.25 ± 195.8 | 397.8 ± 184.1 |
| Carbohydrate Profile | ||||||||
| HbA1c (%) a | 5.21 ± 0.26 | 5.47 ± 0.57 | 5.2 ± 0.24 | 5.54 ± 0.61 | 5.21 ± 0.26 | 5.47 ± 0.57 | 5.2 ± 0.25 | 5.51 ± 0.58 |
| Si [(mu/L)^l.min^-1] b | 11.6 ± 6.3 | 5.9 ± 5.1† | 11.6 ± 6.3 | 5.3 ± 4.4† | 11.6 ± 6.3 | 5.9 ± 5.1† | 11.9 ± 6.0 | 5.0 ± 4.5† |
| Sg [min^-1] | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 |
| Inflammatory Markers | ||||||||
| CRP (ng/mL) | 5774 ± 6841 | 8668 ± 6273 | 6420 ± 6846 | 8182 ± 6457 | 5774 ± 6841 | 8668 ± 6273 | 5455 ± 6615 | 9340 ± 6182 |
| TNF-α (pg/mL) | 11.7 ± 5.6 | 19.0 ± 8.5† | 12.7 ± 6.8 | 18.5 ± 8.4 | 11.7 ± 5.6 | 19.0 ± 8.5† | 11.3 ± 5.4 | 20.1 ± 8.1† |
| IL-6 (pg/mL) | 4.9 ± 4.9 | 6.9 ± 8.4 | 6.0 ± 5.8 | 5.8 ± 8.1 | 4.9 ± 4.9 | 6.9 ± 8.4 | 4.6 ± 4.8 | 7.5 ± 8.6 |
Abdominal circumference; AC, basal metabolic rate; BMR, body mass index; BMI, c-reactive protein; CPR, cross-sectional area; CSA, diastolic blood pressure; DIA, free fatty acid; FFA, glucose effectiveness; Sg, glycated hemoglobin; HbA1c, high-density lipoprotein; HDL-C, hip circumference; HC, insulin sensitivity; Si, interleukin-6; IL-6, low-density lipoprotein; LDL-C, magnetic resonance imaging; MRI, peak oxygen uptake; VO2 peak, subcutaneous adipose tissue; SAT, systolic blood pressure; SYS, triglycerides; TG, tumor necrosis factor alpha; TNF-α, visceral adipose tissue cross sectional area; VATCSA, waist circumference; WC. Missing data:
a n = 21
b n = 19
c n = 15.
†P < 0.05
*P < 0.01.